CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-11 | COLLINS Asha Director | Grant or award · Restricted Stock Unit | +344 | 344 | ||
| 2022-05-11 | AYERS JONATHAN W Director | Exercise or conversion | +224 | 630,420 | ||
| 2022-05-11 | AYERS JONATHAN W Director | Grant or award · Non-Qualified Stock Option (right-to-buy) | +945 | 945 | ||
| 2022-05-11 | AYERS JONATHAN W Director | Grant or award · Restricted Stock Unit | +344 | 568 | ||
| 2022-05-11 | AYERS JONATHAN W Director | Exercise or conversion · Restricted Stock Unit | −224 | 344 | ||
| 2022-04-29 | JUNIUS DANIEL M Director | Grant or award | +15 | $430.48 | $6K | 2,934 |
| 2022-03-04 | MAZELSKY JONATHAN JAY President & CEO | Gift | −500 | 50,585.64 | ||
| 2022-02-23 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion | +706 | $141.60 | $100K | 18,436.48 |
| 2022-02-23 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion | +1,893 | $288.78 | $547K | 20,329.48 |
| 2022-02-23 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2022-02-23 | TWIGGE GIOVANI Senior Vice President | Exercise or conversion · Non-Qualified Stock Option (right-to-buy) | −1,893 | 3,784 | ||
| 2022-02-18 | Turner Kathy V Senior Vice President | Exercise or conversion | +1,474 | $67.85 | $100K | 6,180.39 |
| 2022-02-18 | Turner Kathy V Senior Vice President | Exercise or conversion | +706 | $141.60 | $100K | 6,886.39 |
| 2022-02-18 | Turner Kathy V Senior Vice President | Exercise or conversion · Incentive Stock Option (right-to-buy) | −1,474 | 0 | ||
| 2022-02-18 | Turner Kathy V Senior Vice President | Exercise or conversion · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2022-02-18 | AYERS JONATHAN W Director | Exercise or conversion | +706 | $141.60 | $100K | 630,196 |
| 2022-02-18 | AYERS JONATHAN W Director | Exercise or conversion · Incentive Stock Option (right-to-buy) | −706 | 0 | ||
| 2022-02-17 | Underberg Sharon E. EVP, GC & Corp. Secretary | Exercise or conversion | +483 | $206.94 | $100K | 2,986.99 |
| 2022-02-17 | Underberg Sharon E. EVP, GC & Corp. Secretary | Exercise or conversion · Incentive Stock Option (right-to-buy) | −483 | 966 | ||
| 2022-02-16 | MCKEON BRIAN P Executive VP & CFO | Exercise or conversion | +706 | $141.60 | $100K | 28,153.64 |
Page 56 of 74 · 1,474 trades